ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies

Ischaemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemia–reperfusion injury, in order to improve clinical outcomes in IHD patients. In this regard, alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecour, Sandrine, Bøtker, Hans E., Condorelli, Gianluigi, Davidson, Sean M., Garcia-Dorado, David, Engel, Felix B., Ferdinandy, Peter, Heusch, Gerd, Madonna, Rosalinda, Ovize, Michel, Ruiz-Meana, Marisol, Schulz, Rainer, Sluijter, Joost P.G., Van Laake, Linda W., Yellon, Derek M., Hausenloy, Derek J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Topical Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242141/
https://www.ncbi.nlm.nih.gov/pubmed/25344369
http://dx.doi.org/10.1093/cvr/cvu225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242141/
https://www.ncbi.nlm.nih.gov/pubmed/25344369
http://dx.doi.org/10.1093/cvr/cvu225

Ejemplares similares